Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-04

Clinical Trial Update: Fluconazole Versus Micafungin in Neonates With Candidiasis [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial comparing fluconazole versus micafungin in neonates with candidiasis has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)
  • Mycamine (Micafungin)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Candidiasis | Phase 2, Phase 3 | Status: COMPLETED